![Design, Synthesis, and Biological Evaluation of Aminoindazole Derivatives as Highly Selective Covalent Inhibitors of Wild-Type and Gatekeeper Mutant FGFR4 | Journal of Medicinal Chemistry Design, Synthesis, and Biological Evaluation of Aminoindazole Derivatives as Highly Selective Covalent Inhibitors of Wild-Type and Gatekeeper Mutant FGFR4 | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.2c00096/asset/images/medium/jm2c00096_0008.gif)
Design, Synthesis, and Biological Evaluation of Aminoindazole Derivatives as Highly Selective Covalent Inhibitors of Wild-Type and Gatekeeper Mutant FGFR4 | Journal of Medicinal Chemistry
![Genetic manipulation of the human gut bacterium Eggerthella lenta reveals a widespread family of transcriptional regulators | Nature Communications Genetic manipulation of the human gut bacterium Eggerthella lenta reveals a widespread family of transcriptional regulators | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-33576-3/MediaObjects/41467_2022_33576_Fig1_HTML.png)
Genetic manipulation of the human gut bacterium Eggerthella lenta reveals a widespread family of transcriptional regulators | Nature Communications
![Ado-trastuzumab Emtansine (T-DM1): An Antibody–Drug Conjugate (ADC) for HER2-Positive Breast Cancer | Journal of Medicinal Chemistry Ado-trastuzumab Emtansine (T-DM1): An Antibody–Drug Conjugate (ADC) for HER2-Positive Breast Cancer | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/jm500766w/asset/images/large/jm-2014-00766w_0004.jpeg)
Ado-trastuzumab Emtansine (T-DM1): An Antibody–Drug Conjugate (ADC) for HER2-Positive Breast Cancer | Journal of Medicinal Chemistry
![How Selective Are Pharmacological Inhibitors of Cell-Cycle-Regulating Cyclin-Dependent Kinases? | Journal of Medicinal Chemistry How Selective Are Pharmacological Inhibitors of Cell-Cycle-Regulating Cyclin-Dependent Kinases? | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.8b00049/asset/images/medium/jm-2018-00049p_0008.gif)
How Selective Are Pharmacological Inhibitors of Cell-Cycle-Regulating Cyclin-Dependent Kinases? | Journal of Medicinal Chemistry
![Design and Synthesis of Fibroblast Growth Factor Receptor (FGFR) and Histone Deacetylase (HDAC) Dual Inhibitors for the Treatment of Cancer | Journal of Medicinal Chemistry Design and Synthesis of Fibroblast Growth Factor Receptor (FGFR) and Histone Deacetylase (HDAC) Dual Inhibitors for the Treatment of Cancer | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.2c01413/asset/images/medium/jm2c01413_0011.gif)